DDAH2 and cancer: We can hypothesize that if DDAH has NO-independent effects, then it might be a better anti-cancer target than NO synthases, as NO operates in a bimodal fashion in cancer and can be both pro- and anti-tumorigenic, depending on its concentration and the tumour microenvironment [12, 13].